Metabolic reprogramming of metastatic breast cancer and melanoma by Let-7a microRNA

Oncotarget

Volumn 6, Issue 4, 2015, Pages 2451-2465

  Serguienko, Anastassia ^a,b   Grad, Iwona ^a,b   Wennerstrøm, Anna B ^a,b   Meza Zepeda, Leonardo A ^a,c   Thiede, Bernd ^d   Stratford, Eva W ^a,b   Myklebost, Ola ^a,b,d   Munthe, Else ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Cancer Stem Cell Innovation Centre   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Glycolysis; HMOX1; Mitochondria; OXPHOS; ROS

Indexed keywords

ACETYLCYSTEINE; DOXORUBICIN; LET 7A; MICRORNA; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ENZYME; MIRNLET7 MICRORNA, HUMAN;

ARTICLE; BREAST METASTASIS; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIVITY; ENERGY METABOLISM; GENETIC TRANSFECTION; GLYCOLYSIS; HUMAN; HUMAN CELL; METABOLIC REGULATION; METASTATIC MELANOMA; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; TRIPLE NEGATIVE BREAST CANCER; UPREGULATION; APOPTOSIS; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MELANOMA; METABOLISM; METASTASIS; MITOCHONDRION; NUCLEAR REPROGRAMMING; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLULAR REPROGRAMMING; DOXORUBICIN; ENERGY METABOLISM; ENZYMES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOLYSIS; HUMANS; MELANOMA; MICRORNAS; MITOCHONDRIA; NEOPLASM METASTASIS; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84922971651     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3235     Document Type: Article

References (52)

1. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000; 403(6772):901-906.
2. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Muller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 2000; 408(6808):86-89.
3. Nair VS, Maeda LS and Ioannidis JP. Clinical outcome prediction by microRNAs in human cancer: a systematic review. Journal of the National Cancer Institute. 2012; 104(7):528-540.
4. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, Feig C, Lengyel E and Peter ME. Let-7 expression defines two differentiation stages of cancer. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(27):11400-11405.
5. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J and Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007; 131(6):1109-1123.
6. Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG and Slack FJ. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell cycle (Georgetown, Tex. 2008; 7(6):759-764.
7. Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-674.
8. Lunt SY and Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annual review of cell and developmental biology. 2011; 27:441-464.
9. Jiang P, Du W, Wang X, Mancuso A, Gao X, Wu M and Yang X. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nature cell biology. 2011; 13(3):310-316.
10. Ying H KA, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, Locasale JW, Son J, Zhang H, Coloff JL, Yan H, Wang W, Chen S, Viale A, Zheng H, Paik JH, Lim C, Guimaraes AR, Martin ES, Chang J, Hezel AF, Perry SR, Hu J, Gan B, Xiao Y, Asara JM, Weissleder R, Wang YA, Chin L, Cantley LC, DePinho RA. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 2012.
11. Menendez JA and Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nature reviews. 2007; 7(10):763-777.
12. Liu. Fatty acid synthase causes drug resistance by inhibiting TNF-a and ceramide production. J Lipid Res. 2013.
13. Bellance N, Benard G, Furt F, Begueret H, Smolkova K, Passerieux E, Delage JP, Baste JM, Moreau P and Rossignol R. Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacity. The international journal of biochemistry & cell biology. 2009; 41(12):2566-2577.
14. Parlo RA and Coleman PS. Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria. The truncated Krebs cycle and other metabolic ramifications of mitochondrial membrane cholesterol. The Journal of biological chemistry. 1984; 259(16):9997-10003.
15. Sanchez-Arago M, Chamorro M and Cuezva JM. Selection of cancer cells with repressed mitochondria triggers colon cancer progression. Carcinogenesis. 2010; 31(4):567-576.
16. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, Nomiyama K, Hosokawa K, Sakurada K, Nakagata N, Ikeda Y, Mak TW and Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature. 2004; 431(7011):997-1002.
17. Smith J. Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proceedings of the National Academy of Sciences of the United States of America. 2000.
18. Tormos KV, Anso E, Hamanaka RB, Eisenbart J, Joseph J, Kalyanaraman B and Chandel NS. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell metabolism. 2011; 14(4):537-544.
19. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009; 458(7239):780-783.
20. Jerby L, Wolf L, Denkert C, Stein GY, Hilvo M, Oresic M, Geiger T and Ruppin E. Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer research. 2012; 72(22):5712-5720.
21. Armstrong L, Tilgner K, Saretzki G, Atkinson SP, Stojkovic M, Moreno R, Przyborski S and Lako M. Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem cells (Dayton, Ohio). 2010; 28(4):661-673.
22. Trachootham D, Alexandre J and Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009; 8(7):579-591.
23. Zhu H, Shyh-Chang N, Segre AV, Shinoda G, Shah SP, Einhorn WS, Takeuchi A, Engreitz JM, Hagan JP, Kharas MG, Urbach A, Thornton JE, Triboulet R, Gregory RI, Altshuler D and Daley GQ. The Lin28/let-7 axis regulates glucose metabolism. Cell. 2011; 147(1):81-94.
24. Ma X, Li C, Sun L, Huang D, Li T, He X, Wu G, Yang Z, Zhong X, Song L, Gao P and Zhang H. Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1. Nature communications. 2014; 5:5212.
25. Korshunov SS, Skulachev VP and Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS letters. 1997; 416(1):15-18.
26. Turrens JF. Mitochondrial formation of reactive oxygen species. The Journal of physiology. 2003; 552(Pt 2):335-344.
27. Miwa S and Brand MD. Mitochondrial matrix reactive oxygen species production is very sensitive to mild uncoupling. Biochemical Society transactions. 2003; 31(Pt 6):1300-1301.
28. Hou W, Tian Q, Steuerwald NM, Schrum LW and Bonkovsky HL. The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes. Biochim Biophys Acta. 2012; 1819(11-12):1113-1122.
29. Wang S KE, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)-and p53-dependent pathways. The Journal of biological chemistry. 2004.
30. Ho HY, Cheng ML, Lu FJ, Chou YH, Stern A, Liang CM and Chiu DT. Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts. Free radical biology & medicine. 2000; 29(2):156-169.
31. Fan J, Ye J, Kamphorst JJ, Shlomi T, Thompson CB and Rabinowitz JD. Quantitative flux analysis reveals folate-dependent NADPH production. Nature. 2014.
32. Liu YC, Li F, Handler J, Huang CR, Xiang Y, Neretti N, Sedivy JM, Zeller KI and Dang CV. Global regulation of nucleotide biosynthetic genes by c-Myc. PloS one. 2008; 3(7):e2722.
33. Mannava S, Grachtchouk V, Wheeler LJ, Im M, Zhuang D, Slavina EG, Mathews CK, Shewach DS and Nikiforov MA. Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells. Cell cycle (Georgetown, Tex. 2008; 7(15):2392-2400.
34. Garg D, Henrich S, Salo-Ahen OM, Myllykallio H, Costi MP and Wade RC. Novel approaches for targeting thymidylate synthase to overcome the resistance and toxicity of anticancer drugs. Journal of medicinal chemistry. 2010; 53(18):6539-6549.
35. Yoshii Y, Furukawa T, Oyama N, Hasegawa Y, Kiyono Y, Nishii R, Waki A, Tsuji AB, Sogawa C, Wakizaka H, Fukumura T, Yoshii H, Fujibayashi Y, Lewis JS and Saga T. Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome. PloS one. 2013; 8(5):e64570.
36. Zaytseva YY, Elliott VA, Rychahou P, Mustain WC, Kim JT, Valentino J, Gao T, O'Connor KL, Neltner JM, Lee EY, Weiss HL and Evers BM. Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer. Carcinogenesis. 2014.
37. Pandey PR, Liu W, Xing F, Fukuda K and Watabe K. Anti-cancer drugs targeting fatty acid synthase (FAS). Recent patents on anti-cancer drug discovery. 2012; 7(2):185-197.
38. Joshi AK, Zhang L, Rangan VS and Smith S. Cloning, expression, and characterization of a human 4'-phosphopantetheinyl transferase with broad substrate specificity. The Journal of biological chemistry. 2003; 278(35):33142-33149.
39. Morgan-Lappe SE, Tucker LA, Huang X, Zhang Q, Sarthy AV, Zakula D, Vernetti L, Schurdak M, Wang J and Fesik SW. Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen. Cancer research. 2007; 67(9):4390-4398.
40. Igal RA. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis. 2010; 31(9):1509-1515.
41. D'Autréaux. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nature Reviews Molecular Cell Biology. 2007.
42. Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S, Lin Y, Yao J, Shi J, Kang T, Lorkiewicz P, St Clair D, Hung MC, Evers BM and Zhou BP. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer cell. 2013; 23(3):316-331.
43. Fillmore. Human Breast Cancer Cell Lines Contain Stem-like Cells That Self-renew, Give Rise to Phenotypically Diverse Progeny and Survive Chemotherapy Breast Cancer Research. 2008.
44. Wang X and Moraes CT. Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels. Molecular oncology. 5(5):399-409.
45. Otterbein LE1 BF, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000.
46. Zheng J, Nagda DA, Lajud SA, Kumar S, Mouchli A, Bezpalko O, O'Malley BW, Jr. and Li D. Biliverdin's regulation of reactive oxygen species signalling leads to potent inhibition of proliferative and angiogenic pathways in head and neck cancer. British journal of cancer. 2014; 110(8):2116-2122.
47. Debora Esposito MW, Haley Holway and Slavko Komarnytsky. Bioenergetic characterization of adipogenesis impaired by inflammation The FASEB Journal. 2013.
48. Masters C. Cellular differentiation and the microcompartmentation of glycolysis. Mechanisms of ageing and development. 1991; 61(1):11-22.
49. Venter G, Oerlemans FT, Wijers M, Willemse M, Fransen JA and Wieringa B. Glucose controls morphodynamics of LPS-stimulated macrophages. PloS one. 2014; 9(5):e96786.
50. Schapira AH. Human complex I defects in neurodegenerative diseases. Biochim Biophys Acta. 1998; 1364(2):261-270.
51. Bonora E, Porcelli AM, Gasparre G, Biondi A, Ghelli A, Carelli V, Baracca A, Tallini G, Martinuzzi A, Lenaz G, Rugolo M and Romeo G. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. Cancer research. 2006; 66(12):6087-6096.
52. Trang P, Medina PP, Wiggins JF, Ruffino L, Kelnar K, Omotola M, Homer R, Brown D, Bader AG, Weidhaas JB and Slack FJ. Regression of murine lung tumors by the let-7 microRNA. Oncogene. 2010; 29(11):1580-1587.